Swiss National Bank Boosts Stake in Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Swiss National Bank increased its holdings in Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Get Rating) by 2.5% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 95,344 shares of the company’s stock after buying an additional 2,300 shares during the quarter. Swiss National Bank’s holdings in Apollo Medical were worth $2,821,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of AMEH. JPMorgan Chase & Co. grew its stake in shares of Apollo Medical by 21.0% in the first quarter. JPMorgan Chase & Co. now owns 53,559 shares of the company’s stock worth $2,596,000 after acquiring an additional 9,293 shares during the period. Citigroup Inc. boosted its holdings in Apollo Medical by 12.9% in the first quarter. Citigroup Inc. now owns 32,729 shares of the company’s stock worth $1,587,000 after purchasing an additional 3,734 shares during the last quarter. PNC Financial Services Group Inc. grew its position in Apollo Medical by 49.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 1,563 shares of the company’s stock worth $75,000 after purchasing an additional 520 shares during the period. MetLife Investment Management LLC raised its stake in Apollo Medical by 53.6% during the 1st quarter. MetLife Investment Management LLC now owns 20,211 shares of the company’s stock valued at $980,000 after buying an additional 7,056 shares during the last quarter. Finally, Rhumbline Advisers lifted its holdings in shares of Apollo Medical by 7.5% during the 1st quarter. Rhumbline Advisers now owns 92,806 shares of the company’s stock valued at $4,498,000 after buying an additional 6,484 shares during the period. Hedge funds and other institutional investors own 34.91% of the company’s stock.

Apollo Medical Trading Down 1.0 %

NASDAQ:AMEH opened at $31.24 on Wednesday. Apollo Medical Holdings, Inc. has a one year low of $26.89 and a one year high of $58.00. The business has a fifty day moving average price of $36.49 and a 200-day moving average price of $33.95. The firm has a market capitalization of $1.80 billion, a price-to-earnings ratio of 29.47, a price-to-earnings-growth ratio of 2.14 and a beta of 0.73. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.77 and a quick ratio of 2.77.

Apollo Medical (NASDAQ:AMEH – Get Rating) last issued its quarterly earnings results on Thursday, February 23rd. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.07). Apollo Medical had a return on equity of 10.98% and a net margin of 4.06%. The company had revenue of $294.21 million during the quarter, compared to analysts’ expectations of $264.40 million. Sell-side analysts forecast that Apollo Medical Holdings, Inc. will post 1.19 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on AMEH. Lake Street Capital upped their price objective on Apollo Medical from $40.00 to $60.00 and gave the company a “buy” rating in a research report on Monday, February 27th. Bank of America started coverage on shares of Apollo Medical in a research report on Wednesday, April 12th. They set a “neutral” rating and a $44.00 price target for the company.

About Apollo Medical

(Get Rating)

Apollo Medical Holdings, Inc is a physician-centric, technology-powered, risk-bearing healthcare management company, which engages in the provision of care coordination services and a healthcare delivery platform. The company was founded on November 1, 1985 and is headquartered in Alhambra, CA.